HT
SIOX

HAP Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

HAP Trading’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,600
Closed -$2K – 2952
2021
Q4 		$2K Sell
10,600
-3,300
-24% -$5.86K ﹤0.01% 2414
2021
Q3 		$4K Buy
+13,900
New +$30.2K ﹤0.01% 2233
2021
Q1 		– Sell
-19,200
Closed -$4K – 2707
2020
Q4 		$4K Buy
+19,200
New +$55.9K ﹤0.01% 2071
2018
Q1 		– Sell
-5,663
Closed -$54K – 1241
2017
Q4 		$54K Sell
5,663
-106,800
-95% -$4.79M ﹤0.01% 655
2017
Q3 		$2K Buy
+112,463
New +$19M ﹤0.01% 860

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

HAP Trading's SIOX Position: Q3 2017 in Review

HAP Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2017, closing a stake of 3,458 shares — an estimated $583K sold.

HAP Trading first reported a position in SIOX in Q1 2017 and held it in 2 quarters. The position peaked at $642K in Q2 2017. 114 funds tracked by Wall St. Rank hold SIOX as of Q3 2017.

  • HAP Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • HAP Trading sold 3,458 Sio Gene Therapies Inc. Common Stock shares in Q3 2017, an estimated $583K.
  • HAP Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • HAP Trading's Sio Gene Therapies Inc. Common Stock position peaked at $642K in Q2 2017.
  • 114 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2017.

Based on HAP Trading's 13F filing for Q3 2017, filed 8 Nov 2017.